These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. QBEND10 for the diagnosis of myelodysplastic syndromes in routinely processed bone marrow biopsy specimens. Horny HP, Wehrmann M, Schlicker HU, Eichstaedt A, Clemens MR, Kaiserling E. J Clin Pathol; 1995 Apr; 48(4):291-4. PubMed ID: 7542289 [Abstract] [Full Text] [Related]
5. CD34/QBEND10 immunostaining in bone marrow biopsies: an additional parameter for the diagnosis and classification of myelodysplastic syndromes. Baur AS, Meugé-Moraw C, Schmidt PM, Parlier V, Jotterand M, Delacrétaz F. Eur J Haematol; 2000 Feb; 64(2):71-9. PubMed ID: 10997326 [Abstract] [Full Text] [Related]
6. Growth analysis of marrow CD34-positive hematopoietic progenitor cells in patients with myelodysplastic syndromes. Asano H, Hotta T, Ichihara M, Murate T, Kobayashi M, Saito H. Leukemia; 1994 May; 8(5):833-8. PubMed ID: 7514249 [Abstract] [Full Text] [Related]
7. CD34 immunostaining of bone marrow biopsy specimens is a reliable way to classify the phases of chronic myeloid leukemia. Orazi A, Neiman RS, Cualing H, Heerema NA, John K. Am J Clin Pathol; 1994 Apr; 101(4):426-8. PubMed ID: 7512785 [Abstract] [Full Text] [Related]
8. Therapy-related changes of CD34+ progenitor cells in chronic myeloid leukemia: a morphometric study on sequential trephine biopsies. Thiele J, Kvasnicka HM, Schmitt-Graeff A, Goekce D, Diehl V, Zankovich R, Schaefer HE. J Hematother Stem Cell Res; 2001 Dec; 10(6):827-36. PubMed ID: 11798509 [Abstract] [Full Text] [Related]
14. CD34 immunohistochemistry of bone marrow biopsies: prognostic significance in primary myelodysplastic syndromes. Soligo DA, Oriani A, Annaloro C, Cortelezzi A, Calori R, Pozzoli E, Nosella D, Orazi A, Deliliers GL. Am J Hematol; 1994 May; 46(1):9-17. PubMed ID: 7514357 [Abstract] [Full Text] [Related]
15. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome. Schlesinger M, Silverman LR, Jiang JD, Yagi MJ, Holland JF, Bekesi JG. J Clin Lab Immunol; 1996 May; 48(4):149-66. PubMed ID: 9819667 [Abstract] [Full Text] [Related]